Friday, November 19, 2021

// // Leave a Comment

NICE draft guidance recommends new treatment for spinal muscular atrophy as part of a managed access agreement

The MAA is a special arrangement between NHS England and NHS Improvement and the company Roche. It will allow people to access treatment with risdiplam while more data is collected to address the uncertainties identified by the independent NICE ...

from Google Alert - health https://ift.tt/2Z0OhK4
via IFTTT

0 comments:

Post a Comment